All countries face challenges in making sufficient supplies of blood and blood products available and sustainable, while also ensuring the quality and safety of these products in the face of known and emerging threats to public health. Since 1975, the World Health Assembly (WHA) has highlighted the global need for blood safety and availability. WHA resolutions 63·12, 58·13 and 28·72, The Melbou...

.......................................................................................................................................... 3

introduction:blood-borne infectious agents are one of the main anxieties of blood transfusion organization in all countries. according to who, the blood healthy and blood safety is included ensuring and monitoring of quality and efficiency for all patients requiring blood transfusion. we at the current study intend that survey prevalence hiv ab, hcv ab, hbs ag among blood donors refer to the bl...

transfusion-transmissible infections such as hepatitis b and hepatitis c are among the greatest threats to blood safety for transfusion recipients and pose a serious public health problem. the aim of this study was to assess the epidemiological aspects of hepatitis b and c in kazakhstani donor's blood over the period 2000-2011.the data were obtained from the annual reports of the republican blo...

The safety profile of atomoxetine in the treatment of attention deficit hyperactivity disorder has been studied in many clinical trials. We performed an integrated safety analysis of 15 clinical trials in adults with attention deficit hyperactivity disorder. The analysis pooled patient data into three groups: acute placebo-controlled trials; long-term placebo-controlled trials; all trials. In t...

BACKGROUND Mirasol® pathogen reduction technology (PRT) uses UV light and riboflavin to chemically inactivate pathogens and white blood cells in blood components. In the EU, Mirasol PRT is CE-marked for both plasma and platelet treatment. In Poland, the decision to introduce PRT treatment of the national supply of fresh frozen plasma has spurred interest in evaluating the cost-effectiveness of ...

BACKGROUND Examining professional assessments of a blood product recall/withdrawal and its implications for risk and public health, the paper introduces ideas about perceptions of minimal risk and its management. It also describes the context of publicly funded blood transfusion in Canada and the withdrawal event that is the basis of this study. METHODS Interviews with 45 experts from adminis...